These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36182834)

  • 21. Uniform brain tumor distribution and tumor associated macrophage targeting of systemically administered dendrimers.
    Zhang F; Mastorakos P; Mishra MK; Mangraviti A; Hwang L; Zhou J; Hanes J; Brem H; Olivi A; Tyler B; Kannan RM
    Biomaterials; 2015 Jun; 52():507-16. PubMed ID: 25818456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery.
    Luong D; Kesharwani P; Deshmukh R; Mohd Amin MCI; Gupta U; Greish K; Iyer AK
    Acta Biomater; 2016 Oct; 43():14-29. PubMed ID: 27422195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dendrimers: A versatile nanocarrier for drug delivery and targeting.
    Sherje AP; Jadhav M; Dravyakar BR; Kadam D
    Int J Pharm; 2018 Sep; 548(1):707-720. PubMed ID: 30012508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycosylation of PAMAM dendrimers significantly improves tumor macrophage targeting and specificity in glioblastoma.
    Sharma R; Liaw K; Sharma A; Jimenez A; Chang M; Salazar S; Amlani I; Kannan S; Kannan RM
    J Control Release; 2021 Sep; 337():179-192. PubMed ID: 34274384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surface Engineered Dendrimers in siRNA Delivery and Gene Silencing.
    Tambe V; Thakkar S; Raval N; Sharma D; Kalia K; Tekade RK
    Curr Pharm Des; 2017; 23(20):2952-2975. PubMed ID: 28292248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targeting.
    Bugno J; Hsu HJ; Hong S
    J Drug Target; 2015; 23(7-8):642-50. PubMed ID: 26453160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poly-glutamic dendrimer-based conjugates for cancer vaccination - a computational design for targeted delivery of antigens.
    Moura LIF; Martinho N; Silva LC; Barata TS; Brocchini S; Florindo HF; Zloh M
    J Drug Target; 2017; 25(9-10):873-880. PubMed ID: 28795601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted delivery of Dicer-substrate siRNAs using a dual targeting peptide decorated dendrimer delivery system.
    Liu X; Liu C; Chen C; Bentobji M; Cheillan FA; Piana JT; Qu F; Rocchi P; Peng L
    Nanomedicine; 2014 Nov; 10(8):1627-36. PubMed ID: 24965758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A controllable aptamer-based self-assembled DNA dendrimer for high affinity targeting, bioimaging and drug delivery.
    Zhang H; Ma Y; Xie Y; An Y; Huang Y; Zhu Z; Yang CJ
    Sci Rep; 2015 May; 5():10099. PubMed ID: 25959874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiscale Molecular Simulations Applied to Nucleic Acid-Dendrimer Interactions Studies.
    Márquez-Miranda V; Araya-Durán I; González-Nilo FD
    Curr Pharm Des; 2017 Aug; 23(21):3062-3075. PubMed ID: 28266272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical studies of dendrimer prodrugs.
    Kojima C
    Expert Opin Drug Metab Toxicol; 2015; 11(8):1303-15. PubMed ID: 26028253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PMPC Modified PAMAM Dendrimer Enhances Brain Tumor-Targeted Drug Delivery.
    Ban J; Li S; Zhan Q; Li X; Xing H; Chen N; Long L; Hou X; Zhao J; Yuan X
    Macromol Biosci; 2021 Apr; 21(4):e2000392. PubMed ID: 33506646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide-mediated drug delivery across the blood-brain barrier for targeting brain tumors.
    Jafari B; Pourseif MM; Barar J; Rafi MA; Omidi Y
    Expert Opin Drug Deliv; 2019 Jun; 16(6):583-605. PubMed ID: 31107110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendrimers for Drug Delivery.
    Chauhan AS
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29670005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptide dendrimers as valuable biomaterials in medical sciences.
    Tabatabaei Mirakabad FS; Khoramgah MS; Keshavarz F K; Tabarzad M; Ranjbari J
    Life Sci; 2019 Sep; 233():116754. PubMed ID: 31415768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dendrimers and miktoarm polymers based multivalent nanocarriers for efficient and targeted drug delivery.
    Soliman GM; Sharma A; Maysinger D; Kakkar A
    Chem Commun (Camb); 2011 Sep; 47(34):9572-87. PubMed ID: 21655634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dendrimer as a promising nanocarrier for the delivery of doxorubicin as an anticancer therapeutics.
    Singh V; Kesharwani P
    J Biomater Sci Polym Ed; 2021 Oct; 32(14):1882-1909. PubMed ID: 34078252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PAMAM dendrimer as a talented multifunctional biomimetic nanocarrier for cancer diagnosis and therapy.
    Surekha B; Kommana NS; Dubey SK; Kumar AVP; Shukla R; Kesharwani P
    Colloids Surf B Biointerfaces; 2021 Aug; 204():111837. PubMed ID: 33992888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptide- and saccharide-conjugated dendrimers for targeted drug delivery: a concise review.
    Liu J; Gray WD; Davis ME; Luo Y
    Interface Focus; 2012 Jun; 2(3):307-24. PubMed ID: 23741608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Precisely Defined Polymers for Efficient Gene Delivery.
    He D; Lin H; Yu Y; Shi L; Tu J
    Top Curr Chem (Cham); 2018 Jan; 376(1):2. PubMed ID: 29335799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.